Ohio State Wexner Medical Center wins $14 million award for aspirin dose study

A research team at The Ohio State University Wexner Medical Center and College of Medicine has been approved for a $14 million award from the Patient-Centered Outcomes Research Institute (PCORI) to study whether a higher daily dose of aspirin is more effective in decreasing the risk of dangerous blood pressure complications among some pregnant people.

Hypertension linked to higher dementia risk in middle-aged patients

Study investigates the relationship between hypertension in middle-aged individuals and the increased risk of developing dementia, utilizing the CAIDE score for dementia risk prediction in

April 5, 2024

Ticks could be a new vector for chronic wasting disease

A new study from researchers at the University of Wisconsin–Madison finds that ticks can harbor transmissible amounts of the protein particle that causes Chronic Wasting

July 7, 2023

PwC predicts active 2024 for pharma deals as M&A value climbs

PwC has declared 2023 a “reasonably strong year” for M&A in the pharmaceutical and life sciences sector, despite a slight dip in overall deal volume

December 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.